INTRODUCTION {#SEC1}
============

Bacterial σ factors are key components of RNA polymerases (RNAPs) responsible for gene transcription. The bacterial RNAP holoenzyme includes a core enzyme consisting of five subunits (ααββ′ω) to bind the template DNA and catalyze RNA synthesis, and a dissociable σ subunit from a large number of σ factors to specifically recognize gene promoters ([@B1]). Housekeeping σ factors that are homologues of *Escherichia coli* σ^70^ are responsible for the majority of transcription in exponentially growing cells, while various alternative σ factors control specialized regulons that are activated by specific sources of stress, growth transitions, and morphological changes ([@B2]). Except for a distinct σ^54^ family in some species, most alternative σ factors belong to the σ^70^ family and have diverse sequences and functions ([@B2]). σ^70^ factors are classified into four groups according to sequence and structural homology, including the primary housekeeping σ factors (Group 1) and three alternative σ factors (Groups 2--4) ([@B3]). σ factors of Group 4 are also called extracytoplasmic function (ECF) σ factors, because most of them work with a co-transcribed trans-membrane anti-σ factor which senses the stimulation of external agents, although members of a small subset of ECF σ factors are linked to soluble cytoplasmic anti-σ factors ([@B2],[@B4]). ECF σ factors are significantly divergent in sequence, with relatively large numbers in some organisms. The trans-membrane anti-σ factors generally contain an extracytoplasmic sensory domain, a transmembrane helix, and an intracellular inhibitory domain to specifically bind corresponding σ factors ([@B4]). Recent studies have elucidated the structural and regulatory mechanism of some ECF σ factors, and their large diversity may provide novel regulation strategies and constitute very promising tools for applied synthetic biology ([@B8]). Indeed, ECF σ factors and their promoters have been successfully applied in the design of orthogonal regulators for synthetic biology ([@B9],[@B10]).

The alternative σ^I^ and anti-σ^I^ (i.e. SigI and RsgI) were first discovered in *Bacillus subtilis* as related to the heat-shock response ([@B11]) and they are found widely in Bacilli and Clostridia of Firmicutes ([@B12]). Multiple paralogous σ^I^ and anti-σ^I^ pairs have been discovered in many lignocellulolytic bacteria to regulate the components of secreted multi-enzyme complexes, termed cellulosomes, by sensing the status of environmental polysaccharides ([@B13],[@B14]). Cellulosomes are assembled by specific modular interactions (cohesins and dockerins) between a scaffolding protein and the enzymes, and are considered the most efficient nano-machines for lignocellulose degradation in nature through the synergistic effects of their various component enzymes ([@B15],[@B16]). A number of omics studies have revealed that the expression of cellulosomal enzymes is regulated by the type of extracellular polysaccharide substrate ([@B17]). The σ^I^ and anti-σ^I^ factors were found to play crucial roles in cellulosome regulation, and genomic studies have revealed that several cellulosome-producing bacteria contain 8--16 pairs of σ^I^ and anti-σ^I^ factors ([@B13],[@B14]). Previous studies of σ^I^ and anti-σ^I^ factors in *Clostridium (Ruminiclostridium) thermocellum*, an anaerobic thermophilic lignocellulolytic bacterium that produces complex cellulosomes, have shown that anti-σ^I^s contain a C-terminal module that functions as a polysaccharide-binding component for sensing different types of lignocellulosic substrates in the extracellular environment. The anti-σ^I^s also bear a conserved cytoplasmic region responsible for binding the respective σ^I^. Upon selective binding of the extracellular polysaccharide, the σ^I^ factor is then released from the anti-σ^I^ to activate the transcription of corresponding cellulosomal genes ([@B22]). It has been shown that the recognition between individual σ^I^ and anti-σ^I^ pairs is specific among the multiplicity of homologous σ^I^ and anti-σ^I^ factors, which raises the question of how such specificity is achieved ([@B22]).

The σ^I^s were classified as Group 3 sigma factors based on phylogenetic analysis, but they are distant from other Group 3 members ([@B2]). Further sequence analysis determined that the σ^I^s exhibit many features consistent with ECF σ factors (i.e. Group 4 sigma factors) but show distinct structural features ([@B25]). ECF σ factors generally have σ^70^-homologous σ~2~ and σ~4~ domains for recognition of promoter --10 and --35 regions, respectively. However, σ^I^s have only the σ~2~ domain, and the C-terminal domains (SigI~C~) of σ^I^s have no sequence homology to other known proteins. The anti-σ^I^s share homologous N-terminal regions, including an N-terminal cytoplasmic domain (RsgI~N~), a transmembrane helix, and a periplasmic domain (RsgI~P~), whereas neither RsgI~N~ nor RsgI~P~ has sequence homology to any other known proteins. Therefore, σ^I^ and anti-σ^I^ represent a novel family of alternative σ factors, and determination of their structures is required to understand their functional mechanism. Here, we employed NMR spectroscopy, structural analysis, mutagenesis, and interaction analyses to investigate the structure and functional mechanism of these unique types of σ and anti-σ factors.

MATERIALS AND METHODS {#SEC2}
=====================

Plasmid construction {#SEC2-1}
--------------------

The gene fragments encoding intracellular N-terminal domains of RsgIs, full-length SigIs, and domains of SigIs were amplified by PCR from *C. thermocellum* ATCC 27405 genomic DNA using relevant primers ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). The purified PCR products were ligated into the pET30a, the pET28a, or the pET28a-SMT3 ([@B26]) for different purposes. The constructs using the pET30a vector were used to express SigI1 N-terminal domain (SigI1~N~) and SigI1~C~ containing a C-terminal His~6~-tag. The constructs using the pET28a were used to express SigI2~C~ containing a C-terminal His~6~-tag. The constructs using the pET28a-SMT3 were used to express proteins containing an N-terminal His~6~-SMT3 tag, including RsgI1~N~, RsgI2~N~, and full-length SigI1, whereas the His~6~-SMT3 tag can be removed by the ULP1 protease treatment when needed. The mutants of RsgI1~N~ and SigI1~C~ were constructed by the QuikChange method using designed primers and appropriate templates ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}).

Recombinant protein expression and purification {#SEC2-2}
-----------------------------------------------

The recombinant plasmid pET28a-SMT3-RsgI1~N~ and derived mutants were transformed into *Escherichia coli* Rosseta (DE3), and the other expression vectors were transformed into *E. coli* BL21 (DE3) for protein expression. The bacterial cells were cultured at 37°C, and when the absorbance at 600 nm reached ∼0.8, target protein expression was induced for ∼18 h with 0.5 mM isopropyl β-[d]{.smallcaps}-thiogalactopyranoside (IPTG). Cells were collected by centrifugation at 6000 rpm for 15 min.

All the cell pellets were resuspended in binding buffers of 20 mM Tris, 500 mM NaCl, 30 mM imidazole at pH 8.0 and lysed by high-pressure homogenization (for SigI1~C~) or ultrasonication (for other SigI or RsgI proteins). All the proteins were first purified by the Ni-chelating affinity chromatography using a Histrap column with the elution buffer containing 20 mM Tris, 500 mM NaCl, 500 mM imidazole at pH 8.0. The second step for the protein purification was optimized by considering the different properties for various target proteins. The second step for the proteins RsgI1~N~ and RsgI2~N~ was a ULP1 protease treatment, and the proteins were then passed through a Histrap column to remove the cleaved SMT3 tag. The target proteins were further purified using ion exchange chromatography with a HiTrap SP-FF column (for RsgI1~N~) or a HiTrap Q-FF column (for RsgI2~N~). The binding buffers were 20 mM Bis--Tris at pH 7.0 for RsgI1~N~ and 20 mM Tris--HCl at pH 7.5 for RsgI2~N~. The proteins were eluted by adding 1 M NaCl into the corresponding binding buffers. The second purification step of the proteins SigI1~C~, SigI1~N~ and SigI2~C~ was gel filtration with a HiLoad 16/600 Superdex 75 column with buffers of 20 mM Tris, 150 mM NaCl at pH 8.0 (for SigI1~C~) or 7.5 (for SigI2~C~) and 20 mM Bis--Tris, 150 mM NaCl at pH 6.8 (for SigI1~N~,). The complex of SigI1~C~--RsgI1~N~ was obtained by mixing the purified RsgI1~N~ and SigI1~C~ and was further purified by gel filtration with a HiLoad 16/600 Superdex 75 column with buffers of 20 mM Tris, 150 mM NaCl at pH 8.0. The purification procedures of RsgI1~N~ and SigI1~C~ mutants were the same as those of the wild-type proteins. During purification, all protein solutions and buffers were kept on ice. The final purity of proteins was detected by SDS-PAGE. The samples were exchanged by dialysis or ultrafiltration with appropriate buffers for subsequent NMR and SPR experiments.

The ^15^N- and ^13^C-labeled proteins for NMR experiments were obtained by cell cultivation using M9 minimal medium containing ^15^N-NH~4~Cl and ^13^C-glucose as sole nitrogen and carbon sources, respectively. The labeled proteins were purified using the same procedures as the unlabeled proteins.

NMR spectroscopy and structural calculations {#SEC2-3}
--------------------------------------------

Protein samples for NMR experiments were dissolved in various optimized buffers containing 90% H~2~O, 10% D~2~O and 0.02% (w/v) sodium 2,2-dimethylsilapentane-5-sulfonate (DSS). The buffer for RsgI1~N~ was 20 mM Bis--Tris, 50 mM NaCl, 2 mM EDTA at pH 6.2; the buffer for the RsgI1~N~--SigI1~C~ complex was 20 mM Bis--Tris, 50 mM NaCl, 2 mM EDTA at pH 6.5. All NMR experiments were performed at 298 K on a Bruker Avance III 600 MHz NMR spectrometer using a *z*-gradient triple resonance cryoprobe, except that the NOESY spectra of the RsgI1~N~--SigI1~C~ complex were acquired on a Bruker Avance III 850 MHz NMR spectrometer. NMR data for chemical shift assignments include 2D ^1^H--^15^N HSQC, 2D ^1^H--^13^C HSQC, 3D ^1^H--^13^C--^15^N HNCACB, CBCA(CO)NH, HNCA, HNCO, HN(CA)CO, HBHA(CBCA)(CO)NH, HBHA(CBCA)NH, H(C)CH-TOCSY, (H)CCH-TOCSY, H(C)CH-COSY and (H)CCH-COSY. The NOESY spectra for distance restraints of structure calculation include ^1^H--^15^N NOESY-HSQC and ^1^H--^13^C NOESY-HSQC. The mixing time for NOESY experiments was 200 ms for RsgI1~N~ and 120 ms for the RsgI1~N~--SigI1~C~ complex. All the spectra were processed using NMRPipe ([@B27]) and analyzed using NMRViewJ ([@B28]). The backbone chemical shift assignments were obtained using the program MARS ([@B29]) with manual verification. The side chain assignments were obtained manually in NMRViewJ ([@B28]).

The initial structures were calculated using the program CYANA ([@B30]) and refined using SANE ([@B31]) and CNS ([@B32]) with explicit water refinement protocol implemented in RECOORDScripts ([@B33]). The dihedral angle restraints of backbone φ, ψ, and side chain χ~1~ obtained by the program TALOS-N ([@B34]) were used in the structure calculation. The hydrogen bond restraints according to the secondary structural elements were also used in the late stage of structure refinements. The final structures were validated by PROCHECK_NMR ([@B35]) and WHAT_CHECK ([@B36]). MOLMOL ([@B37]) and PyMol (<http://www.pymol.org/>) were used for visual structure validation and structure figure plotting.

The search for structure homology was performed using the Dali server ([@B38]) and SSM server ([@B39]). The structural alignments were obtained using the SSM server ([@B39]).

Homology modeling {#SEC2-4}
-----------------

The structure models of the RsgIx~N~--SigIx~C~ (*x* = 2--8) complexes were obtained using the program Modeller ([@B40]). The NMR structure of the RsgI1~N~--SigI1~C~ complex was used as the template, and the sequence alignments were obtained by ClustalX ([@B41]).

Surface plasmon resonance (SPR) experiments {#SEC2-5}
-------------------------------------------

SPR experiments were performed on Biacore T100 (GE healthcare) with Series S Sensor Chip NTA (GE healthcare). The buffer containing 20 mM Tris--HCl, 50 mM NaCl, 0.05% Triton X-100 at pH 7.5 was used in the experiments. The standard Single Cycle Kinetics (SCK) ([@B42]) protocol was used in the SPR experiments and analysis. Each experiment was repeated three times.

Expression and purification of RNA polymerase from *C. thermocellum* {#SEC2-6}
--------------------------------------------------------------------

The gene of the β′ subunit of RNA polymerase (RNAP) was amplified by PCR from *C. thermocellum* DSM 1313 genomic DNA. The primers contained an additional coding region for adding 10 histidines at the C-terminus of the β′ subunit. The amplified DNA fragment was inserted into a pHK plasmid ([@B43]) for protein expression in *C. thermocellum* DSM 1313. The plasmid pHK-β′ was transformed into the *C. thermocellum* DSM 1313. The correct transformants were amplified into 3 L of GS-2 media for fermentation. The cells were harvested by centrifugation at 10 200 *g* for 30 min and lysed by ultrasonication. The RNAP core enzyme complex (ααββ′ω) was first purified by affinity chromatography with a Histrap column using the elution buffer of 20 mM Tris--HCl, 500 mM NaCl, 500 mM imidazole, at pH 8.0. The complex was further purified by heparin affinity chromatography using a HiTrap Heparin HP column. The binding buffer was 20 mM Tris--HCl, 100 mM NaCl, 5% (v/v) glycerol, pH 8.0, and the elution buffer was 20 mM Tris--HCl, 1 M NaCl, 5% (v/v) glycerol, pH 8.0. The α, β, β′ and ω subunits in the purified RNAP core enzyme complex were identified by SDS-PAGE and HPLC-Q-TOF high resolution mass spectrometry.

The holoenzyme of RNAP was prepared by adding purified SigI1 into a solution containing the core enzyme. The full length SigI1 was expressed with an His~6~-SMT3 tag and purified by Ni-chelating affinity chromatography. After ULP1 protease treatment, the mixture of SigI1 and His~6~-SMT3 was excessively added into the solution of the RNAP core enzyme. The protein mixture was then applied onto a HiLoad 26/600 Superdex 200 column with a buffer containing 20 mM Tris--HCl, 150 mM NaCl at pH 8.0. The RNAP holoenzyme (ααββ′ω-SigI1), the excess SigI1 and His~6~-SMT3 eluted at different elution volumes. In the competition experiment, the purified RsgI1~N~ was added to the holoenzyme with a molar ratio of 1.3:1, and the mixture was applied onto the HiLoad 26/600 Superdex 200 column. Different components were collected and detected by SDS-PAGE.

Electrophoretic mobility shift assay {#SEC2-7}
------------------------------------

The electrophoretic mobility shift assay was performed using the native polyacrylamide gel electrophoresis. A 12% polyacrylamide gel was prepared with buffer containing 5× Tris-borate-EDTA (TBE) buffer at pH 8.3. The promoter --35 region DNAs (5′-ATCGATAATATACACAAAAA-3′ of *SigI1* and 5′-TTATTGGTATCCCCCGAAAA-3′ of *SigI2*) were synthesized and annealed. Samples contained 500 ng promoter DNA and different molar ratios of SigI1~C~ (or SigI1~C~ mutants). The electrophoresis was performed using a buffer containing 0.5× TBE buffer at pH 8.3. The polyacrylamide gel was dyed with ethidium bromide and detected with ultraviolet transilluminator.

RESULTS {#SEC3}
=======

RsgI1~N~ shows a β-barrel structure which is unique among all anti-sigma factors {#SEC3-1}
--------------------------------------------------------------------------------

The N-terminal domains of RsgI factors in *C. thermocellum* generally contain 50--60 residues and have 12--40% sequence identity to each other ([Supplementary Figure S1 and Table S3](#sup1){ref-type="supplementary-material"}). Among the nine RsgIs from *C. thermocellum*, RsgI1 contains a CBM3-type C-terminal domain, which was demonstrated to recognize cellulose ([@B22]). The promoter sequence recognized by the cognate SigI1 has been analyzed, and SigI1 can recognize the promoter of major cellulosomal components, including Cel48S and Cel8A ([@B22],[@B25]). Therefore, we chose RsgI1 and SigI1 to study the structure and interaction of σ^I^ and anti-σ^I^ factors. RsgI1~N~ showed good solubility and well-dispersed peaks in the ^1^H--^15^N HSQC NMR spectrum ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}), suggesting that it has a well-folded structure and is suitable for structure determination by NMR spectroscopy. The NMR structure of RsgI1~N~ was finally determined to high quality as indicated by the statistics in [Supplementary Table S4](#sup1){ref-type="supplementary-material"}.

The structure of RsgI1~N~ contains four anti-parallel β-strands and a short C-terminal 3~10~ helix, which exhibits a β-barrel structure (Figure [1A](#F1){ref-type="fig"} and [B](#F1){ref-type="fig"}). The central portion of the barrel comprises the hydrophobic core, formed by I7, I10, A15, V17, L25, I27, M33, V35, V39, F41 and I46, which are largely conserved in all RsgIs. Hydrophobic residues, including L4, I6, M13, V16, L18, F24 and I26, are exposed on the surface and are not conserved in all RsgIs. RsgI1~N~ is the inhibitory domain of RsgI1, because RsgI1~N~ specifically binds to SigI1 and inhibits the transcriptional activity of the RNAP-SigI1 complex ([@B22]). Interestingly, the β-barrel structure of RsgI1~N~ is completely different from those of known anti-sigma factors, which have α-helical structures as the inhibitory domains, according to previous reports ([@B44]). Therefore, the RsgIs represent a unique family of anti-sigma factors.

![NMR structures of RsgI1~N~. (**A**) Stereo view of the backbone ensemble of 20 RsgI1~N~ structures. (**B**) Ribbon representation of the RsgI1~N~ structure. Secondary structure elements are labeled on the structure. (**C**) Superposition of RsgI1~N~ (gray) and its structurally homologous protein, metallochaperone HypC (PDB 3VYS, magenta) from *Thermococcus kodakarensis*.](gkz355fig1){#F1}

Despite the lack of sequence homology to known protein structures as determined by Blast search of the Protein Data Bank (PDB), we continued to examine potential structural homology of RsgI1~N~ in the PDB, using the Dali and SSM servers. Both servers identified a large number of proteins with significant structural similarity. The structure with the highest Dali Z score is a metallochaperone HypC (PDB 3vyt:A, *Z*-score 6.1, RMSD 1.7 Å) from *Thermococcus kodakarensis* ([@B47]) (Figure [1C](#F1){ref-type="fig"}). Most of the structurally similar proteins have OB (oligonucleotide/oligosaccharide binding)-fold domains. Classical OB-fold domains consist of five β-strands that form a closed β-barrel and an extra α-helix between β3 and β4 ([@B48],[@B49]). The OB-fold proteins also show great structural diversity with additional secondary structural elements or lack of either the β5 or the α-helix ([@B50]). RsgI1~N~ represented a simplified OB-fold which lacks both β5 and the α-helix. OB-fold proteins have high functional diversity ([@B49]) and no OB-fold protein has previously been found among the anti-σ factors, so the structural similarity with OB-fold proteins does not tell us the functional mechanism of RsgI1~N~.

SigI1 binds to RsgI1~N~ through its C-terminal domain {#SEC3-2}
-----------------------------------------------------

To gain insight into the inhibitory mechanism of RsgI~N~ towards SigI, we first investigated the interaction of SigI1 and RsgI1~N~. The purification of full-length SigI1 was difficult because SigI1 is prone to precipitation. SigI contains an N-terminal domain (SigI1~N~), which is homologous to the σ~2~ domain of σ^70^ factors, and a putative C-terminal domain (SigI1~C~), which has no sequence homology to other proteins and is proposed to be functionally similar to the σ~4~ domain of σ^70^ factors. Because the structures of both the σ~2~ and σ~4~ domains of σ^70^ have been determined ([@B51],[@B52]), we tried to purify SigI1~N~ and SigI1~C~ separately and found that each domain was more stable than the full-length protein. Although both domains are soluble and could be successfully purified, their ^1^H--^15^N HSQC NMR spectra showed poor spectral quality, indicating that they are aggregated under the conditions for solution NMR (i.e. concentrations in the μM to mM range). In NMR titration experiments the ^1^H--^15^N HSQC spectra of SigI1~N~ and RsgI1~N~ showed slight, gradual changes, which suggests a weak interaction between them ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). However, the ^1^H--^15^N HSQC spectra of RsgI1~N~ and SigI1~C~ showed dramatic changes during the titration and no further change in the spectrum was observed when the ratio was over 1:1, indicating strong and equimolar binding of SigI1~C~ and RsgI1~N~.

Furthermore, we investigated whether RsgI1~N~ can inhibit holoenzyme formation of SigI1 and RNAP. The β′ subunit of *C. thermocellum* RNAP was overexpressed in *C. thermocellum* using a plasmid containing the β′ subunit gene with an additional C-terminal His~10~-tag. The RNAP was successfully purified from the recombinant *C. thermocellum*, and the bands of RNAP subunits on SDS-PAGE gels were verified by mass spectrometry ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). SigI1, expressed and purified in *E. coli*, was then added to the RNAP, and the holoenzyme would be purified by gel filtration if SigI1 and RNAP can form a complex. SigI1 was eluted together with RNAP, thus indicating formation of the holoenzyme (Figure [2A](#F2){ref-type="fig"} and [C](#F2){ref-type="fig"}). However, when RsgI1~N~ was added into the solution containing the holoenzyme, the SigI1 band was significantly weakened in the eluted RNAP fraction and appeared in a separate fraction with RsgI1~N~ (Figure [2B](#F2){ref-type="fig"} and [C](#F2){ref-type="fig"}). These results indicate that RsgI1~N~ inhibits SigI1 by preventing it from interacting with RNAP, and the binding affinity between RsgI1~N~ and SigI1 is much higher than that between SigI1 and the RNAP core enzyme.

![RsgI1~N~ prevents SigI1 from binding to RNA polymerase. (**A**) Purification of the RNAP-SigI1 complex. The chromatography of the mixture of full-length recombinant SigI1 (containing a SMT3 tag) purified from *E. coli* and RNAP from *C. thermocellum* was performed using a Superdex200 gel filtration column. The fractions of peak b represent the RNAP-SigI1 complex. (**B**) Gel filtration chromatography of the RNAP--SigI1 complex (peak b in Figure A) after addition of RsgI1~N~. (**C**) SDS-PAGE of samples after the gel filtration steps. Lane M is the molecular weight marker; lane RNAP is the purified RNAP from *C. thermocellum*; lane SigI1 + SMT3 is the purified SigI1 and SMT3 after ULP1 protease treatment; other lanes are labeled according to the eluted fraction numbers indicated in Panels A and B by red arrows.](gkz355fig2){#F2}

The structure of the SigI1~C~--RsgI1~N~ complex represents a novel structural type of alternative σ/anti-σ complex {#SEC3-3}
------------------------------------------------------------------------------------------------------------------

The NMR titration experiments showed the complex of SigI1~C~ and RsgI1~N~ has a well-dispersed ^1^H--^15^N HSQC spectrum and is suitable for NMR structure determination ([Supplementary Figure S3 and S5](#sup1){ref-type="supplementary-material"}). High-quality structures of the SigI1~C~--RsgI1~N~ complex were determined using NMR (Figure [3A](#F3){ref-type="fig"}), and the final structural statistics of the structures are shown in [Supplementary Table S4](#sup1){ref-type="supplementary-material"}. In the structure of the SigI1~C~--RsgI1~N~ complex, RsgI1~N~ forms a simplified OB-fold structure almost identical to the structure of the free RsgI1~N~. A slight difference in the C-terminal region including the 3~10~ helix and the flexible tail of RsgI1~N~ was observed, which is likely caused by the hydrophobic interaction between V49 of RsgI1~N~ and V167-L168 of SigI1~C~ ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}). SigI1~C~ is composed of eight α-helices, and the interacting surface includes the outer surfaces of all four β-strands of RsgI1~N~ and helices α1, α2, α3, α7 and α8 of SigI1~C~, with 1132 ± 56 Å^2^ buried surface area (Figure [3B](#F3){ref-type="fig"}). These α-helices of SigI1~C~ are stacked mainly involving hydrophobic interactions, while the packing between SigI1~C~ and RsgI1~N~ involves hydrophobic, hydrogen-bonding, and electrostatic interactions (Figure [3C](#F3){ref-type="fig"} and [D](#F3){ref-type="fig"}).

![The structure of the SigI1~C~--RsgI1~N~ complex and the interaction between SigI1~C~ and RsgI1~N~. (**A**) Stereo view of the backbone ensemble of 20 SigI1~C~-RsgI1~N~ complex structures. SigI1~C~ is colored in blue and RsgI1~N~ is in yellow. (**B**) Ribbon representation of the overall SigI1~C~--RsgI1~N~ complex. (**C**) The interaction between SigI1~C~ and RsgI1~N~ in the structure. Key interaction residues from SigI1~C~ (blue) and RsgI1~N~ (yellow) are shown as sticks and are labeled. (**D**) The interaction network in the SigI1~C~--RsgI1~N~ complex. Residues at the corresponding positions in other SigIs and RsgIs are also shown. The black, red and green lines represent the hydrophobic, electrostatic, and hydrogen-bonding interactions, respectively.](gkz355fig3){#F3}

The structure of SigI1~C~ is clearly distinct from the σ~4~ domain of other σ^70^ factors (Figure [4](#F4){ref-type="fig"}). The structure of SigI1~C~ resembles a compact globular protein, whereas the σ~4~ domain is more extended and composed of four helices which form two helix-turn-helix (HTH) motifs to bind the -35 region of the promoter DNA ([@B44],[@B52]). Previously known anti-σ factors bind both the σ~2~ and the σ~4~ domains of ECF sigma factors by forming either a σ~2~/anti-σ/σ~4~ sandwich structure or an anti-σ factor-embracing a compact σ~2~/σ~4~ structure (Figure [4A](#F4){ref-type="fig"}--[C](#F4){ref-type="fig"}) ([@B8],[@B46],[@B53]). In contrast, the binding interface of SigI1~C~ and RsgI1~N~ is located at one side of the globular SigI1~C~ molecule with a large buried surface area (Figure [4D](#F4){ref-type="fig"}). Therefore, the structure of the SigI1~C~-RsgI1~N~ complex represents a novel structural type of alternative σ/anti-σ complex, completely distinct, according to the structural characteristics, from the three known classes of these complexes ([@B3],[@B46],[@B53]).

![The structure of the SigI1~C~-RsgI1~N~ complex is distinct from known structures of ECF anti-σ factors. SigE-RseA, CnrH-CnrY and BldN-RsbN are the σ/anti-σ factors from *Mycobacterium tuberculosis, Rhodobacter sphaeroides* and *Streptomyces venezuelae*, respectively. The σ~2~ domains, σ~4~ domains, anti-σ factors, and SigI~C~ are in red, green, cyan and yellow, respectively.](gkz355fig4){#F4}

Structure analysis reveals the promoter binding region on SigI1~C~ {#SEC3-4}
------------------------------------------------------------------

Because SigI1~C~ has no sequence homology to other proteins in the PDB, we used the Dali and SSM servers to identify proteins with structural similarity. Both servers identified many nucleic acid binding proteins, some of which are transcriptional regulators containing helix-turn-helix (HTH) motifs. For example, the protein Lmo0178 (PDB 5F7Q, Dali *Z* score 4.2, RMSD 3.0 Å) is a transcriptional repressor, which recognizes the operator of its operon by binding to the major and minor groove of DNA using its HTH domain and an additional loop, respectively ([@B54]). It is known that the basic core HTH domain generally contains three-helix bundles which recognize the major groove of the target DNA region ([@B55],[@B56]). Interestingly, the α-helices (α3, α5, and α6) of SigI1~C~ shared high homology with the HTH domain of Lmo0178 (Figure [5A](#F5){ref-type="fig"}), thus suggesting that SigI1~C~ may play a potential role in DNA binding. Analysis of the corresponding α-helices of SigI1~C~ revealed that many positively charged residues are distributed on these three helices (Figure [5C](#F5){ref-type="fig"} and [D](#F5){ref-type="fig"}). However, sequence alignment of the eight SigI~C~s in *C. thermocellum* indicates that most of these residues are not conserved ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Nevertheless, on every modelled SigI~C~ structure, these regions contain basic residues at different positions which allow these regions to form positively charged surfaces (Figure [6](#F6){ref-type="fig"}). Therefore, we speculate that the three helices of SigI~C~ contain the putative DNA binding region for specific recognition of the promoter -35 regions of the target genes.

![Structural comparison of SigI1~C~ with transcriptional factors and σ~4~ domain reveals the promoter binding site of SigI1~C~. (**A**) Structural superposition of SigI1~C~ (gray) and a transcription repressor--DNA complex (PDB 5F7Q, green) from *Listeria monocytogenes*. (**B**) Structural superposition of SigI1~C~ (gray) and SigE (PDB 2H27, red) in complex with the --35 region promoter DNA from *E. coli*. (**C**) Positively charged residues on the proposed DNA binding sites of SigI1~C~. (**D**) Electrostatic surface of SigI1~C~. The positively and negatively charged surfaces are colored in blue and red, respectively. The residues involved in the proposed promoter-binding region are labeled. (**E**) EMSAs of SigI1~C~ and -35 region promoter DNA. The promoter from SigI1 (PSigI1) was used in the assays of SigI1~C~ and its single (R217E) and double (K209E/R217E) mutants (first three panels). The promoter from SigI2 (PSigI2) was also used in an assay of SigI1~C~ (last panel). Lanes 1--6 are the samples with the DNA:protein molar ratio of 1:0, 1:0.5, 1:1, 1:2, 1:4, 1:8. Lane 7 is a sample containing the promoter DNA and BSA with molar ratio of 1:8.](gkz355fig5){#F5}

![Electrostatic surfaces of SigI~C~ structures. The structures of SigI2~C~-SigI8~C~ were obtained by homology modeling using the SigI1~C~ structure as the template. Positively charged residues on the proposed DNA binding sites are shown as sticks. Electrostatic surfaces are shown in blue and red for positively and negatively charged surfaces, respectively.](gkz355fig6){#F6}

Previous studies have revealed that the σ^70^ family sigma factors have a σ~4~ domain which also belongs to the HTH group of structures and the σ~4~ domains recognize the major groove of DNA with several similar conserved sites ([@B57],[@B58]). We tried to align the structure of SigI1~C~ with a known σ~4~ domain structure (PDB 2H27) ([@B57]) using the SSM server, and found they could also be aligned at the DNA-binding region of the σ~4~ domain with low scores (SSM *Q*-score 0.0698, RMSD 2.975) (Figure [5B](#F5){ref-type="fig"}). Helices α3, α5, and α6 of SigI1~C~ are indeed similar to the helices of σ^E^ in the major groove of the DNA, but loops L~23~ and L~45~ of SigI1~C~ would clash with the DNA in this binding mode. Therefore, if this region is the --35 promotor-binding region of SigI, it must either have a different binding mode or it undergoes additional conformational changes when it binds RNAP to form the active holoenzyme.

To further validate the proposed promoter binding region of SigI1~C~, electrophoretic mobility shift assays (EMSAs) were performed to detect the binding of SigI1~C~ and its mutants with the *SigI1* promoter --35 region DNA (Figure [5E](#F5){ref-type="fig"}). The results show that the wild-type SigI1~C~ can bind well to the promoter DNA, while the single mutant on the proposed binding region significantly weakens the binding and the double mutation can abolish the binding completely. Therefore, the positively charged region on SigI1~C~ is responsible for the promoter binding. The region is on the opposite side of the RsgI-binding surface, which is consistent with the proposal that RsgI inhibits the activity of SigI by blocking RNAP binding instead of promoter binding.

Mutagenesis analysis reveals the structural basis for the specific σ^I^/anti-σ^I^ interactions {#SEC3-5}
----------------------------------------------------------------------------------------------

The structure of the SigI1~C~--RsgI1~N~ complex indicates that the large interfacial surfaces and consequent interactions are involved in the formation of the complex. We constructed several RsgI1~N~ variants with mutated interfacial residues to examine the importance of these residues in the interaction. The correct folding of RsgI1~N~ mutants was confirmed by NMR experiments ([Supplementary Figure S7](#sup1){ref-type="supplementary-material"}). Surface plasmon resonance (SPR) experiments were performed to check the affinity of SigI1~C~ and RsgI1~N~ mutants (Table [1](#tbl1){ref-type="table"}). Wild-type RsgI1~N~ showed very strong binding to SigI1~C~, the equilibrium dissociation constants for which reached values of 10^−11^ M. The results showed that most of the single mutations of interfacial residues weakened the interaction between the two proteins, such as E9G, Y8L and V16K, which reduced the electrostatic, hydrogen bonding, and hydrophobic interactions, respectively. However, none of these mutations fully abolished complex formation. When all of the negatively charged residues (E9, E21 and E23) were mutated simultaneously to positively charged lysine, the interaction decreased dramatically and binding was not detectable by SPR. Therefore, multiple interactions contribute synergistically to the strong SigI--RsgI interaction. Additionally, the configuration of hydrophobic residues is also important since the mutants V16I, L18I and F24I showed weakened interactions.

###### 

Equilibrium dissociation constants for interaction between SigI1~C~ and wild-type (WT) or mutants of RsgI1~N~

  RsgI1~N~        *K* ~D~ (M)
  --------------- ----------------------
  WT              1.1 ± 0.4 × 10^--11^
  Y8L             8.4 ± 0.9 × 10^--11^
  Y8I             4.5 ± 0.5 × 10^--10^
  E9K             9.7 ± 2.7 × 10^--11^
  E9G             7.1 ± 1.4 × 10^--11^
  V16I            3.6 ± 0.7 × 10^--10^
  V16K            2.4 ± 0.9 × 10^--9^
  L18I            6.7 ± 0.2 × 10^--10^
  L18F            3.1 ± 0.9 × 10^--12^
  E21K            1.6 ± 0.1 × 10^--11^
  E23K            3.6 ± 1.0 × 10^--10^
  F24I            1.9 ± 0.5 × 10^--10^
  V35K            6.5 ± 1.6 × 10^--12^
  V35I            2.3 ± 1.0 × 10^--11^
  Y8L-E9K         1.6 ± 0.6 × 10^--10^
  Y8L-V35R        4.0 ± 0.7 × 10^--11^
  E9K-E21K        2.0 ± 0.3 × 10^--11^
  E9K-E23K        6.4 ± 0.9 × 10^-9^
  Y8L-E9K-V35R    9.3 ± 0.8 × 10^-9^
  E9K-E21K-E23K   Not detected

Although different SigI--RsgI pairs share significant homology ([Supplementary Table S3](#sup1){ref-type="supplementary-material"}), the structure of the SigI1~C~--RsgI1~N~ complex and the sequence alignments indicate that the interfacial residues are not well conserved (Figure [3D](#F3){ref-type="fig"}, [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). At least eight residues are different among the 16 and 20 interfacial residues of RsgI and SigI, respectively, and only G36 of RsgI1 and L166 of SigI1 are completely conserved in the eight SigI--RsgI pairs (Figure [3D](#F3){ref-type="fig"}, [Supplementary Table S5](#sup1){ref-type="supplementary-material"}). This phenomenon is consistent with the specific recognition of multiple SigI--RsgI pairs.

To further understand the structural basis for the specific recognition, we performed structural and mutagenesis analyses, using two pairs of σ^I^/anti-σ^I^ factors, SigI1/RsgI1 and SigI2/RsgI2, as examples. By comparing the interfacial interactions in the structure of the SigI1~C~--RsgI1~N~ complex and the structural model of SigI2~C~-RsgI2~N~ ([Supplementary Table S6](#sup1){ref-type="supplementary-material"}), we selected residues Y8, E9 and V35 of RsgI1~N~ which form hydrogen bonding, electrostatic, and hydrophobic interactions with SigI1~C~, respectively, and the corresponding residues L9, K10 and R36 of RsgI2~N~ which form hydrophobic, reversed electrostatic, and new electrostatic interactions with SigI2~C~, respectively. Therefore, these residues may play roles in the specific recognition for SigI1/RsgI1 and SigI2/RsgI2 pairs. Because SigI2~C~ showed non-specific binding to the SPR chip and was unstable during the SPR experiments, we used NMR titration experiments to check the interactions by adding wild-type RsgI1~N~, the Y8L, Y8L-E9K or Y8L-E9K-V35R mutants, or wild-type RsgI2~N~ into a solution of ^15^N-labeled SigI1~C~ or SigI2~C~ ([Supplementary Figure S8](#sup1){ref-type="supplementary-material"}). The results indicate that these mutations increasingly weaken the interaction with SigI1~C~ but enhance interaction with SigI2~C~. The triple mutant of RsgI1~N~, however, still failed to abolish the interaction with SigI1~C~ completely, and its interaction with SigI2~C~ was not as strong as wild-type RsgI2~N~, indicating that multiple interfacial residues contribute synergistically to the specificity of the two pairs of σ^I^/anti-σ^I^ factors.

DISCUSSION {#SEC4}
==========

SigI and RsgI are distinctive pairs of alternative σ/anti-σ factors. In this study, we presented the structures and recognition mechanisms of the key domains of SigI and RsgI, which were discovered to be notably different from all other known σ/anti-σ factors. The results reveal a novel β-barrel inhibitory domain structure for RsgI and a distinct 8-helical structure for SigI~C~, which differs from the well-known σ~4~ domain of σ^70^ factors. The 3D structure of the SigI1~C~--RsgI1~N~ complex revealed the structural basis of the specific recognition between multiple pairs of σ^I^/anti-σ^I^ factors. Previous studies have shown that the --35 element is important for the specific recognition of promoters by different SigIs ([@B25]), and our analysis of the SigI1~C~ structure revealed the promoter binding site of SigI~C~ for --35 region recognition. The low sequence homology of the interaction regions for either RsgI binding or promoter recognition provides the functional specificity of each σ^I^-anti-σ^I^ pair.

Analysis of the interactions between SigI1~C~, RsgI1~N~ and RNAP revealed that RsgI blocks holoenzyme formation of RNAP and SigI. This suggests the presence of overlapping binding surfaces on SigI for interaction with RNAP or RsgI, and that the SigI~C~ domain is important for RNAP binding. The different SigIs presumably share a conserved RNAP-binding surface to form holoenzymes with RNAP. However, the RsgI-binding surfaces of SigIs showed largely non-conserved residues for specific recognition of their cognate RsgIs. One possible explanation is that SigI~C~ may undergo significant conformational changes to expose highly conserved regions upon RNAP binding. Future structure determination of the RNAP holoenzyme is thus needed to address this issue.

The 3D structure of the SigI1~C~--RsgI1~N~ complex presented in this paper also provides the structural basis for analysis of the multiple SigI and RsgI factors in other bacterial species. Studies on the structure and specificity of σ^I^, anti-σ^I^, and the cognitive promoters will enhance our understanding of the molecular mechanism of these intricate systems. Furthermore, the large number of σ^I^/anti-σ^I^ pairs in the different species provides an abundant library of regulatory components. Recently, the exquisite specificity of ECF σ factors has been successfully used in the design of orthogonal genetic switches and regulators in synthetic genetic circuits ([@B9],[@B10]). The σ^I^/anti-σ^I^ systems with alternative specificities are also promising components for the development of novel genetic circuits. Understanding the fine structural and molecular details of the various σ^I^-anti-σ^I^ systems from different sources can provide a future basis for advanced regulatory design in synthetic biology.

DATA AVAILABILITY {#SEC5}
=================

The structures and the chemical shift assignments have been deposited into Protein Data Bank and the BioMagResBank under accession numbers 6IVS and 36220 for RsgI1~N~ and 6IVU and 36221 for the RsgI1~N~--SigI1~C~ complex, respectively.
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